Local business owners have raised concerns about Bristol's proposed move to monthly bin collections, with storage and hygiene ...

This was the stock's third consecutive day of losses.

The Super Bowl on Sunday is not just a big day for football fans; it is also one of the busiest days of the year for local ...

Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...

On This Week in Connecticut, Dennis House talks with Bristol Mayor Jeff Caggiano about reelection, red light cameras, ...

Bristol Myers Squibb will cut $2 billion in costs by the end of 2027, a move aimed at long-term growth as the company prepares for patent expirations on key treatments, CNBC reported Feb. 6.

Shares in Bristol-Myers Squibb traded about 2.7% lower Thursday after the drug maker gave 2025 guidance that undershot ...

Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

Bristol Myers Squibb said it has received positive results for its latest lymphoma treatment trials, the fifth type of cancer the drug has been shown to treat.

Follow live coverage as Bristol City face Swansea City in the Championship today. An increasingly competitive second tier in ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...